Paper679195
Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in culture.
Sweeney MJ and 10 others. Cancer Res, 1978. Cited by 46 papers, by iCite.
Cite this record
ConductScience Library. Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in culture. Papers, record 679195. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/679195
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Antitumor activity of deacetyl vinblastine amide sulfate (vindesine) in rodents and mitotic accumulation studies in culture.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antineoplastic Agents | Major topic |
| Mitosis | Major topic |
| Neoplasms, Experimental | Major topic |
| Vinca Alkaloids | Major topic |
| Animals | |
| Ascites | |
| Cells, Cultured | |
| Humans | |
| Leukemia, Experimental | |
| Metaphase | |
| Mice | |
| Nervous System | |
| Rats | |
| Vincristine |
Source PubMed
Cited by9
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 46 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 31182083 | Inhibiting eukaryotic ribosome biogenesis. | BMC Biol | 2019 | https://conductscience.org/library/papers/31182083 | PubMed |
| 7265281 | Immunopotentiating effect of vinca alkaloids on the antibody response to sheep red blood cells in the mouse. | J Natl Med Assoc | 1981 | https://conductscience.org/library/papers/7265281 | PubMed |
| 7105380 | Establishment of Vincristine-resistant and vindesine-resistant lines of murine lymphoblasts in vitro and characterisation of their patterns of cross-resistance and drug sensitivities. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/7105380 | PubMed |
| 6957273 | Vindesine effect in myeloid leukemia. | Cancer Chemother Pharmacol | 1982 | https://conductscience.org/library/papers/6957273 | PubMed |
| 6733843 | The use of a fluorescent methotrexate probe to monitor the effects of three vinca alkaloids on a mixed population of parental L1210 and gene-amplified methotrexate-resistant cells by flow cytometry. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6733843 | PubMed |
| 6733842 | The effect of vinca alkaloids in enhancing the sensitivity of a methotrexate-resistant (L1210/R7A) line, studied by flow cytometric and chromosome number analysis. | Cancer Chemother Pharmacol | 1984 | https://conductscience.org/library/papers/6733842 | PubMed |
| 2191847 | Antineoplastic drugs in 1990. A review (Part II). | Drugs | 1990 | https://conductscience.org/library/papers/2191847 | PubMed |
| 455582 | Correlation of the clinical neurotoxicity of the vinca alkaloids vincristine, vinblastine, and vindesine with their effects on cultured rat midbrain cells. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/455582 | PubMed |
| 287569 | Phase-II trial with vindesine for regression induction in patients with leukemias and hematosarcomas. | Cancer Chemother Pharmacol | 1979 | https://conductscience.org/library/papers/287569 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/679195
GET https://conductscience.org/api/papers/v1/679195/authors